市場調查報告書
商品編碼
1403383
微球市場至2030年的預測:按產品類型、原料、應用和地區分類的全球分析Microspheres Market Forecasts to 2030 - Global Analysis By Product Type, Raw Material, Application and By Geography |
根據Stratistics MRC的資料,2023年全球微球市場規模為24億美元,預計到2030年將達到60.8億美元,預測期內年複合成長率為14.2%。
微球是小球形顆粒,直徑通常為 1 至 1000 微米(μm)。通常由多種材料製成,包括聚合物、玻璃、陶瓷和金屬。微球廣泛應用於醫學、製藥、化妝品、材料科學等各領域。此外,微球的小尺寸和均勻的形狀使其對於精密應用很有價值,並且其多功能性使其能夠針對廣泛行業中的特定功能進行客製化。
根據 OECD 的資料,2021年美國醫療保健支出將佔國內生產總值(GDP)的 17.8%,而2020年為 18.8%。
醫療保健需求不斷成長
微球用於各種醫療應用,以發揮藥物輸送的功能。在醫學影像中,它也用作顯影劑以幫助視力和診斷,在再生醫學中,它有助於組織工程和細胞培養。此外,對微創手術和個人化醫療的日益重視增加了醫療保健行業對微球的需求,推動了市場擴張。
初始成本高
特別是在生產生物相容性或生物分解性的微球時,由於製造過程困難和特殊材料的使用,生產成本可能會增加。這些令人望而卻步的費用可能會導致含有微球的藥物和醫療程序的成本增加,限制了患者的可及性和負擔能力。此外,經濟負擔可能會阻止小規模生產商進入市場,限制基於微球的創意醫療解決方案的進步,並阻礙市場成長。
生態學穩定的進展
隨著醫療保健行業越來越關注永續性,微球提供了一種解決方案,可以最大限度地減少醫療保健對環境的影響。生物分解性微球應用於永續包裝解決方案,以減少各種產品的環境足跡。此外,研究和開發工作的重點是利用再生資源創建微球,有助於實現生態系統穩定的整體目標。隨著生態考量成為商業策略的組成部分,它們的採用將推動該市場的成長。
缺乏意識和標準化
在各種醫療應用中也缺乏使用微球的標準化指南,這可能會影響患者的安全和結果。這種缺乏統一性對監管合規性和品質保證造成了障礙,導致利用率不足和錯失為患者提供更好護理的機會。此外,製造商對將微球涵蓋其產品的潛在好處的認知有限,可能會導致錯失創新和效率提高的機會,阻礙市場規模。
COVID-19 的爆發在多個方面對微球市場產生了負面影響。供應鏈中斷、旅行限制和勞動力短缺給微球製造商帶來了營運挑戰。由於消費者支出和建設計劃的減少,對廣泛用於汽車、化妝品和建設產業的微球的需求有所下降。此外,醫療保健行業的收緊以及微球相關手術的擱置逐漸阻礙了該市場的成長。
預計中空區隔在預測期內將是最大的
據估計,中空區隔佔最大佔有率。中空球密度低,因此在混凝土和油漆等中用作輕量填充材。它廣泛應用於石油和天然氣、油漆和塗料、複合材料以及減輕重量以提高強度重量比的材料等多種行業。此外,在醫療應用中,中空微球在成像技術中用作顯影劑,提高診斷過程中的可視性。
預計粉煤灰領域在預測期內的年複合成長率最高。
預計粉煤灰細分市場在預測期內的年複合成長率最高。粉煤灰微球可作為混凝土中的輕量填充材,提高強度、耐用性和絕緣性。飛灰微球由於其潤滑性和浮力特性而用於石油和天然氣工業的鑽井液中。此外,粉煤灰微球市場符合永續實踐,因為它將工業廢棄物(粉煤灰)回收為有價值的材料,有助於減少廢棄物和環境保護,使該領域推動成長。
該地區處於尖端醫療創新和研究的前沿,開拓了各種醫療應用的創新微球技術。個人化醫療、精準藥物輸送以及生物相容性和生物分解性微球的開發都是其中的一些進步。此外,歐洲的技術突破帶來了嚴格的品質標準和監管法規,推動了該地區的成長。
預計亞太地區在預測期內年複合成長率最高。各國政府製定計劃和政策,鼓勵使用和探索基於微球的醫療保健創新。中國和印度等國家擴大在基礎設施計劃的輕量混凝土中採用微球。該地區擁有致力於永續醫療保健解決方案和技術進步的主要企業,例如Siemens Healthineers AG、3M、Kureha Corporation和Potters Industries LLC,這些公司推動該地區的成長。
According to Stratistics MRC, the Global Microspheres Market is accounted for $2.40 billion in 2023 and is expected to reach $6.08 billion by 2030 growing at a CAGR of 14.2% during the forecast period. Microspheres are tiny spherical particles with diameters typically ranging from 1 to 1000 micrometers (μm). They are often made from various materials, including polymers, glass, ceramics, and metals. Microspheres find extensive use in various fields, such as medicine, pharmaceuticals, cosmetics, and materials science. Furthermore, the small size and uniform shape of microspheres make them valuable for precise applications, and their versatility allows them to be customized for specific functions in a wide range of industries.
According to the OECD, the healthcare expenditure accounted for 17.8% of United States' gross domestic product (GDP) in 2021, compared to 18.8% in 2020.
Microspheres are used in many different medical applications as they perform the role of drug delivery vehicles, allowing for the regulated release of medications, improving the effectiveness of treatment, and minimizing negative effects. In medical imaging, these are also used as contrast agents to help with vision and diagnosis, as they facilitate tissue engineering and cell culture in regenerative medicine. Furthermore, the need for microspheres in the healthcare industry is increasing because of the growing emphasis on minimally invasive procedures and personalized medicine, which are driving this market expansion.
Production costs may rise as a result of difficult manufacturing procedures and the use of specialty materials, particularly when creating biocompatible or biodegradable microspheres. These outrageous expenses may consequently raise the cost of microsphere-containing medications or medical procedures, limiting patient accessibility and affordability. Furthermore, the financial strain could discourage smaller producers from entering the market and restrict the advancement of creative healthcare solutions based on microspheres, which hampers market growth.
Microspheres provide solutions that minimize the environmental impact of medical treatments as the healthcare industry places an increasing emphasis on sustainability. Biodegradable microspheres find applications in sustainable packaging solutions, reducing the environmental footprint of various products. Furthermore, research and development efforts are focused on creating microspheres from renewable resources, contributing to the overall goal of achieving ecological stability. As ecological considerations become integral to business strategies, the adoption of these will drive this market's growth.
Standardized guidelines for the use of microspheres in various medical applications are also lacking, which could have an impact on patient safety and outcomes. This lack of uniformity can create hurdles in regulatory compliance and quality assurance, resulting in inadequate utilization and lost chances to provide patients with better care. Moreover, the limited awareness among manufacturers about the potential advantages of incorporating microspheres in their products may result in missed opportunities for innovation and efficiency improvements, thereby hampering this market size.
The COVID-19 pandemic has adversely affected the microsphere market in several ways. Supply chain disruptions, travel restrictions, and workforce shortages have led to operational challenges for microsphere manufacturers. The demand for microspheres, which are widely utilized in the automotive, cosmetics, and construction industries, has declined as a result of a reduction in consumer expenditure and construction projects. Furthermore, the healthcare industry was under pressure, and microsphere-related surgical procedures were put on hold, which gradually impeded this market growth.
The hollow segment is estimated to hold the largest share. These are utilized as lightweight fillers in materials such as concrete and coatings due to their low density. They are widely used in a variety of industries, including oil and gas, paints and coatings, composites, and materials whose strength-to-weight ratios can be enhanced by their lightweight nature. Furthermore, in medical applications, hollow microspheres serve as contrast agents in imaging techniques, providing enhanced visibility in diagnostic procedures.
The fly ash segment is anticipated to have highest CAGR during the forecast period. These microspheres act as lightweight fillers in concrete, enhancing its strength, durability, and insulation properties. Fly ash microspheres are used in drilling fluids in the oil and gas industry because of their lubricating and buoyant qualities. Furthermore, the fly ash microsphere market aligns with sustainable practices, as it involves repurposing industrial waste (fly ash) into valuable materials, contributing to waste reduction and environmental conservation, which are propelling this segment's growth.
Europe commanded the largest market share during the extrapolated period owing to the fact that the area is at the forefront of cutting-edge medical innovation and research, which has led to the development of innovative microsphere technologies for a range of healthcare uses. Personalized medicine, precision medication delivery, and the creation of biocompatible and biodegradable microspheres are some of these advancements. Furthermore, strict quality standards and regulatory regulations have been put in place as a result of Europe's technical breakthroughs, which are driving this region's growth.
Asia Pacific is expected to witness highest CAGR over the projection period. To encourage the usage and research of microsphere-based healthcare innovations, governments have launched programs and policies. In countries like China and India, the adoption of microspheres in lightweight concrete for infrastructure projects is on the rise. This region is home to major key players, including Siemens Healthineers AG, 3M, Kureha Corporation, and Potters Industries LLC, dedicated to sustainable healthcare solutions and technological advancement, which are boosting this region's growth.
Some of the key players in the Microspheres Market include 3M, Trelleborg AB, Bangs Laboratories Inc., Siemens Healthineers AG, Potters Industries LLC, Chase Corporation, Nouryon, Cospheric LLC, Mo-sci Corporation (Heraeus Holdings), Kureha Corporation, Momentive, Luminex Corporation (Diasorin Spa), Merit Medical Systems and Matsumoto Yushi-seiyaku Co. Ltd.
In August 2023, 3M announced it has completed the sale of certain assets from its dental local anesthetic portfolio, based in Seefeld, Germany, to Pierrel S.p.A., a global provider of services for the pharmaceutical industry, for a purchase price of $70 million, subject to closing and other adjustments.
In July 2023, Chase, announced that it has entered into a definitive agreement to be acquired by an affiliate of investment funds managed by KKR, a leading global investment firm.
In July 2023, 3M Health Information Systems (HIS) announced that U.S. News & World Report will incorporate the 3M™ Ambulatory Potentially Preventable Complications software in the analysis of its 2023-2024 Best Hospitals Specialty rankings.